| Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model ED Roberson, K Scearce-Levie, JJ Palop, F Yan, IH Cheng, T Wu, ... Science 316 (5825), 750-754, 2007 | 2353 | 2007 |
| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2257 | 2019 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2158 | 2011 |
| Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease JJ Palop, J Chin, ED Roberson, J Wang, MT Thwin, N Bien-Ly, J Yoo, ... Neuron 55 (5), 697-711, 2007 | 1714 | 2007 |
| Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans Nature communications 7 (1), 11934, 2016 | 1010 | 2016 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 919 | 2017 |
| Amyloid-β/Fyn–induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease ED Roberson, B Halabisky, JW Yoo, J Yao, J Chin, F Yan, T Wu, P Hamto, ... Journal of Neuroscience 31 (2), 700-711, 2011 | 756 | 2011 |
| 100 years and counting: prospects for defeating Alzheimer's disease ED Roberson, L Mucke science 314 (5800), 781-784, 2006 | 746 | 2006 |
| The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus ED Roberson, JD English, JP Adams, JC Selcher, C Kondratick, ... Journal of Neuroscience 19 (11), 4337-4348, 1999 | 664 | 1999 |
| Frontotemporal lobar degeneration: demographic characteristics of 353 patients JK Johnson, J Diehl, MF Mendez, J Neuhaus, JS Shapira, M Forman, ... Archives of neurology 62 (6), 925-930, 2005 | 571 | 2005 |
| Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease S Mueller-Steiner, Y Zhou, H Arai, ED Roberson, B Sun, J Chen, X Wang, ... Neuron 51 (6), 703-714, 2006 | 528 | 2006 |
| Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes G Jun, AC Naj, GW Beecham, LS Wang, J Buros, PJ Gallins, JD Buxbaum, ... Archives of neurology 67 (12), 1473-1484, 2010 | 502 | 2010 |
| Plasma tau in Alzheimer disease N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ... Neurology 87 (17), 1827-1835, 2016 | 484 | 2016 |
| Incidence and impact of subclinical epileptiform activity in Alzheimer's disease KA Vossel, KG Ranasinghe, AJ Beagle, D Mizuiri, SM Honma, ... Annals of neurology 80 (6), 858-870, 2016 | 449 | 2016 |
| Mouse models of Alzheimer's disease AM Hall, ED Roberson Brain research bulletin 88 (1), 3-12, 2012 | 407 | 2012 |
| Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis DC Whitcomb, J LaRusch, AM Krasinskas, L Klei, JP Smith, RE Brand, ... Nature genetics 44 (12), 1349-1354, 2012 | 401 | 2012 |
| Frontotemporal dementia progresses to death faster than Alzheimer disease ED Roberson, JH Hesse, KD Rose, H Slama, JK Johnson, K Yaffe, ... Neurology 65 (5), 719-725, 2005 | 375 | 2005 |
| Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE S Ayton, NG Faux, AI Bush Nature communications 6 (1), 6760, 2015 | 297 | 2015 |
| Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ... The Lancet Neurology 13 (7), 676-685, 2014 | 296 | 2014 |
| ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects H Qiu, S Lee, Y Shang, WY Wang, KF Au, S Kamiya, SJ Barmada, ... The Journal of clinical investigation 124 (3), 981-999, 2014 | 296 | 2014 |
